1.89% -0.9794

Harrow Inc (HROW)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché HROW Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Harrow Inc Stock (HROW) Company Profile

Healthcare (1120)

615.733.4731

1A BURTON HILLS BLVD, NASHVILLE, CA

Prossima data di guadagno

Ultimi documenti SEC

HROW's Discussions on Twitter

Confronta HROW con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HROW Harrow Inc	46.23	1.75B	154.15M	-33.58M	-20.74M	-0.96
ZTS Zoetis Inc	124.03	55.12B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	15.97	50.80B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	10.27	45.60B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	31.64	36.04B	16.88B	666.71M	251.19M	0.6132
UTHR United Therapeutics Corp	470.62	20.23B	3.08B	1.24B	1.07B	25.61

Harrow Inc Stock (HROW) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-07-11	Iniziato	Cantor Fitzgerald	Overweight
2025-06-12	Iniziato	BTIG Research	Buy
2025-06-10	Iniziato	William Blair	Outperform
2025-02-06	Iniziato	H.C. Wainwright	Buy
2024-12-04	Reiterato	B. Riley Securities	Buy
2024-04-11	Iniziato	Craig Hallum	Buy
2022-09-08	Ripresa	B. Riley Securities	Buy
2021-10-14	Ripresa	B. Riley Securities	Buy
2021-09-24	Iniziato	Aegis Capital	Buy
2021-07-02	Iniziato	Ladenburg Thalmann	Buy

Mostra tutto

Harrow Inc Borsa (HROW) Ultime notizie

Harrow Inc Azioni (HROW) Dati Finanziari

Harrow Inc Azioni (HROW) insider trading

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
BOLL ANDREW R.	PRESIDENT AND CFO	Dec 12 '25	Option Exercise	3.95	60,000	237,000	837,844
BAUM MARK L	CHIEF EXECUTIVE OFFICER	Dec 12 '25	Option Exercise	3.95	180,000	711,000	3,066,124
BAUM MARK L	CHIEF EXECUTIVE OFFICER	Jul 21 '25	Option Exercise	7.87	600,000	4,722,000	3,199,462
Opaleye Management Inc.	10% Owner	Jun 10 '25	Sale	30.80	15,000	462,033	90,000
Opaleye Management Inc.	10% Owner	Jun 09 '25	Sale	30.37	15,204	461,794	105,000
Opaleye Management Inc.	10% Owner	Jun 03 '25	Sale	30.04	3,000	90,116	122,000
Opaleye Management Inc.	10% Owner	Jun 04 '25	Sale	30.02	1,796	53,907	120,204
Opaleye Management Inc.	10% Owner	May 12 '25	Sale	25.90	10,000	258,959	130,000
Opaleye Management Inc.	10% Owner	May 13 '25	Sale	26.59	5,000	132,945	125,000
BOLL ANDREW R.	Chief Financial Officer	Apr 03 '25	Option Exercise	0.00	346,500	0	914,589

Harrow Inc (HROW)

Harrow Inc Stock (HROW) Company Profile

Confronta HROW con altri titoli

Harrow Inc Stock (HROW) Upgrades & Downgrades

Harrow Inc Borsa (HROW) Ultime notizie

Harrow (NASDAQ:HROW) Shares Down 4.4%Time to Sell? - MarketBeat

Harrow Health (NASDAQ:HROW) Expanding Clinical Reach In Ophthalmology - Kalkine Media

Market Trends: Can Harrow Inc expand into new marketsJuly 2025 Drop Watch & AI Enhanced Execution Alerts - baoquankhu1.vn

Pharma News: Can Harrow Inc. be recession proofTrade Risk Assessment & Weekly High Return Stock Forecasts - baoquankhu1.vn

Investment Recap: Can OptimizeRx Corporation weather a recessionQuarterly Trade Review & Weekly Setup with ROI Potential - baoquankhu1.vn

Breakeven Is Near for Harrow, Inc. (NASDAQ:HROW) - Yahoo Finance

LJI Wealth Management LLC Makes New Investment in Harrow, Inc. $HROW - MarketBeat

Opaleye management sells $711,814 worth of Harrow shares - MSN

Harrow announces leadership changes, Andrew Boll to serve as President and CFO - MSN

Harrow, Inc. (NASDAQ:HROW) Could Be Less Than A Year Away From Profitability - 富途资讯

Here's What Could Help Harrow (HROW) Maintain Its Recent Price Strength - sharewise.com

Harrow, Inc. (HROW): A Bull Case Theory - Finviz

Zacks Research Upgrades Harrow (NASDAQ:HROW) to "Strong-Buy" - MarketBeat

Gap Down: Can Harrow Inc maintain sales growthBull Run & Safe Capital Allocation Plans - baoquankhu1.vn

Panic Selling: What are the future prospects of Harrow IncTrade Exit Summary & Real-Time Volume Analysis - baoquankhu1.vn

Harrow: Flirting With Missing 2025 Revised Guidance (NASDAQ:HROW) - Seeking Alpha

Value Recap: Will Harrow Inc benefit from geopolitical trendsWeekly Trend Summary & Weekly Momentum Stock Picks - baoquankhu1.vn

Responsive Playbooks and the HROW Inflection - Stock Traders Daily

Institution Moves: Is Harrow Inc stock attractive for ETFsTrade Analysis Summary & Low Drawdown Investment Strategies - moha.gov.vn

Harrow Stock (-8.3%): Major Holder Sale Near Highs Sparks Distribution - Trefis

Is Harrow Inc. stock a good choice for value investorsJuly 2025 Spike Watch & Technical Pattern Recognition Alerts - Улправда

Harrow (NASDAQ:HROW) Trading Down 6%Here's What Happened - MarketBeat

How Harrow Inc. stock compares to growth peers2025 Short Interest & Accurate Trade Setup Notifications - Улправда

Major Harrow Health Backer Quietly Unloads a Chunk of Shares - TipRanks

Why Harrow Inc. stock remains a top recommendationMarket Growth Summary & Daily Price Action Insights - Улправда

Will Harrow Inc. stock deliver shareholder value2025 Key Lessons & Daily Stock Momentum Reports - Улправда

Harrow Health stock hits 52-week high at 54.85 USD - Investing.com

Harrow Health stock hits 52-week high at 54.85 USD By Investing.com - Investing.com South Africa

Most Volatile Stocks in the US (January 2026) - Investing.com

Harrow, Inc. (HROW) Stock Analysis: Navigating a 28.88% Upside Potential Amidst Robust Revenue Growth - DirectorsTalk Interviews

Harrow (NASDAQ:HROW) Hits New 12-Month HighWhat's Next? - MarketBeat

HARROW INC (NASDAQ:HROW) Emerges as a High-Growth Momentum Stock with Strong Technical Setup - Chartmill

Calamos Advisors LLC Makes New $1.09 Million Investment in Harrow, Inc. $HROW - MarketBeat

Harrow (NASDAQ:HROW) Hits New 1-Year HighTime to Buy? - MarketBeat

Harrow Health stock hits 52-week high at 51.38 USD - Investing.com

Harrow Health stock hits 52-week high at 51.38 USD By Investing.com - Investing.com UK

Harrow, Inc. (NASDAQ:HROW) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Brookstone Capital Management Grows Stock Holdings in Harrow, Inc. $HROW - MarketBeat

Harrow, Inc. $HROW Shares Sold by Rice Hall James & Associates LLC - MarketBeat

Harrow (NASDAQ:HROW) Has A Somewhat Strained Balance Sheet - 富途牛牛

Squarepoint Ops LLC Has $640,000 Stock Holdings in Harrow, Inc. $HROW - MarketBeat

First Week of February 2026 Options Trading For Harrow (HROW) - Nasdaq

Is Harrow Inc. stock vulnerable to regulatory risksJuly 2025 PreEarnings & Daily Technical Stock Forecast Reports - bolumsonucanavari.com

Will Harrow Inc. stock gain from strong economyAnalyst Downgrade & Stepwise Trade Signal Guides - Улправда

What margin trends mean for Harrow Inc. stockQuarterly Portfolio Summary & Long-Term Capital Growth Strategies - DonanımHaber

Why Harrow Inc. stock appeals to dividend seekersJuly 2025 Intraday Action & Real-Time Volume Trigger Notifications - Улправда

Insider Buy: Can Harrow Inc. stock resist market sell offsRate Hike & Free Accurate Trade Setup Notifications - ulpravda.ru

Is Harrow Inc. stock attractive for income investorsMarket Performance Report & Consistent Growth Equity Picks - Улправда

CFO Boll Acquires 33,335 Of Harrow Inc [HROW] - TradingView — Track All Markets

Harrow (HROW) CEO Mark Baum exercises 180,000 stock options in company - Stock Titan

Harrow (NASDAQ:HROW) Trading Down 5.8%Should You Sell? - MarketBeat

Harrow Inc Azioni (HROW) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Harrow Inc Azioni (HROW) insider trading

Simile a HROW